يعرض 1 - 20 نتائج من 46 نتيجة بحث عن '"E V Verenikina"', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المساهمون: this work was not funded., финансирование данной работы не проводилось.

    المصدر: Research and Practical Medicine Journal; Том 11, № 4 (2024); 58-72 ; Research'n Practical Medicine Journal; Том 11, № 4 (2024); 58-72 ; 2410-1893 ; 10.17709/2410-1893-2024-11-4

    وصف الملف: application/pdf

    Relation: https://www.rpmj.ru/rpmj/article/view/1028/664; Liu J, Wang Z. Advances in the Preoperative Identification of Uterine Sarcoma. Cancers (Basel). 2022 Jul 20;14(14):3517. doi:10.3390/cancers14143517; He X, Dong Q, Weng C, Gu J, Yang Q, Yang G. Trends in incidence, survival and initial treatments of gynecological sarcoma: a retrospective analysis of the United States subpopulation. BMC Womens Health. 2023 Jan 9;23(1):10. doi:10.1186/s12905‑023‑02161‑1; Mallmann P. Uterine Sarcoma ‑ Difficult to Diagnose, Hard to Treat. Oncol Res Treat. 2018;41(11):674. doi:10.1159/000494393; Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma : A review of the literature and update on management options. Gynecol Oncol. 2018 Dec;151(3):562–572. doi:10.1016/j.ygyno.2018.09.010; Arend R, Doneza JA, Wright JD. Uterine carcinosarcoma. Curr Opin Oncol. 2011 Sep;23(5):531–536. doi:10.1097/CCO.0b013e328349a45b; Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol. 2014 Nov;21(6):383–393. doi:10.1097/pap.0000000000000046; Cotzia P, Benayed R, Mullaney K, Oliva E, Felix A, Ferreira J, et al. Undifferentiated Uterine Sarcomas Represent Under‑Recognized High‑grade Endometrial Stromal Sarcomas. Am J Surg Pathol. 2019 May;43(5):662–669. doi:10.1097/pas.0000000000001215; Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine Adenosarcoma : a Review. Curr Oncol Rep. 2016 Nov;18(11):68. doi:10.1007/s11912‑016‑0552‑7; Нечушкина В. М., Коломиец Л. А., Кравец О. А., Морхов К. Ю., Новикова Е. Г., Новикова О. В., и др. Рак тела матки и саркомы матки. Злокачественные опухоли. 2023;13(3S2‑1):263–279. doi:10.18027/2224‑5057‑2023‑13‑3s2‑1‑263‑279; Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, et al. A primary xenograft model of small‑cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res. 2009 Apr 15;69(8):3364–3373. doi:10.1158/0008‑5472.can‑08‑4210; Франциянц E. М., Каплиева И. В., Бандовкина В. А., Сурикова Е. И., Нескубина И. В., Трипитаки Л. К., и др. Моделирование первично‑множественных злокачественных опухолей в эксперименте. Южно‑Российский онкологический журнал. 2022;3(2):14–21. doi:10.37748/2686‑9039‑2022‑3‑2‑2; Кит О. И., Франциянц Е. М., Каплиева И. В., Сурикова Е. И., Трепитаки Л. К., Нескубина И. В., Лесовая Н. С. Способ отмены генетически детерминированного ингибирования роста злокачественной опухоли в эксперименте. Патент на изобретение RU 2718671 C1, 13. 04. 2020. Заявка № 2019124739 от 01. 08. 2019.; Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM, et al. Patient‑derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol. 2012 Apr 17;9(6):338–350. doi:10.1038/nrclinonc.2012.61; Izumchenko E, Paz K, Ciznadija D, Sloma I, Katz A, Vasquez‑Dunddel D, et al. Patient‑derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors. Ann Oncol. 2017 Oct 1;28(10):2595–2605. doi:10.1093/annonc/mdx416; Moiola CP, Lopez‑Gil C, Cabrera S, Garcia A, Van Nyen T, Annibali D, et al. Patient‑Derived Xenograft Models for Endometrial Cancer Research. Int J Mol Sci. 2018 Aug 17;19(8):2431. doi:10.3390/ijms19082431; Guerin MV, Finisguerra V, Van den Eynde BJ, Bercovici N, Trautmann A. Preclinical murine tumor models: a structural and functional perspective. Elife. 2020 Jan 28;9:e50740. doi:10.7554/elife.50740; Побяржин В. В., Пашинская Е. С., Семенов В. М., Гончаров А. Е. Методологические аспекты постановки онкологических моделей в условиях эксперимента. Вестник ВГМУ. 2018;17(6):32–45. doi:10.22263/2312‑4156.2018.6.32; Vollmer G. Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis. Endocr Relat Cancer. 2003 Mar;10(1):23–42. doi:10.1677/erc.0.0100023; Kawabe S, Mizutani T, Ishikane S, Martinez ME, Kiyono Y, Miura K, et al. Establishment and characterization of a novel orthotopic mouse model for human uterine sarcoma with different metastatic potentials. Cancer Lett. 2015 Oct 1;366(2):182–190. doi:10.1016/j.canlet.2015.06.018; Cuppens T, Depreeuw J, Annibali D, Thomas D, Hermans E, Gommé E, et al. Establishment and characterization of uterine sarcoma and carcinosarcoma patient‑derived xenograft models. Gynecol Oncol. 2017 Sep;146(3):538–545. doi:10.1016/j.ygyno.2017.06.005; Garcia N, Ulin M, Ali M, Al‑Hendy A, Carvalho KC, Yang Q. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model. Reprod Sci. 2022 Mar;29(3):781–790. doi:10.1007/s43032‑021‑00731‑y; Noh JJ, Cho YJ, Ryu JY, Choi JJ, Hwang JR, Choi JY, Lee JW. Anticancer Activity of the Combination of Cabozantinib and Temozolomide in Uterine Sarcoma. Clin Cancer Res. 2022 Sep 1;28(17):3850–3861. doi:10.1158/1078‑0432.ccr‑22‑0985; Zhang W, Fan W, Rachagani S, Zhou Z, Lele SM, Batra SK, Garrison JC. Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r‑Targeting Efficacy. Sci Rep. 2019 Jul 31;9(1):11117. doi:10.1038/s41598‑019‑47308‑z; Модели и методы экспериментальной онкологии. Под ред. А. Д. Тимофеевского. М.: «Медгиз»; 1960 г.; Mbatani N, Olawaiye AB, Prat J. Uterine sarcomas. Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:51–58. doi:10.1002/ijgo.12613; Hoang L, Chiang S, Lee CH. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology. 2018 Feb;50(2):162–177. doi:10.1016/j.pathol.2017.11.086; Lewis D, Liang A, Mason T, Ferriss JS. Current Treatment Options: Uterine Sarcoma. Curr Treat Options Oncol. 2024 Jul;25(7):829–853. doi:10.1007/s11864‑024‑01214‑3; Франциянц Е. М., Шихлярова А. И., Каплиева И. В., Бандовкина В. А., Погорелова Ю. А., Нескубина И. В., и др. Способ создания модели саркомы матки. Патент на изобретение RU 2820404 C1, 03. 06. 2024. Заявка № 2024104813 от 27. 02. 2024.; https://www.rpmj.ru/rpmj/article/view/1028

  7. 7
    Academic Journal

    المساهمون: this work was not funded., финансирование данной работы не проводилось.

    المصدر: Research and Practical Medicine Journal; Том 11, № 4 (2024); 23-35 ; Research'n Practical Medicine Journal; Том 11, № 4 (2024); 23-35 ; 2410-1893 ; 10.17709/2410-1893-2024-11-4

    وصف الملف: application/pdf

    Relation: https://www.rpmj.ru/rpmj/article/view/1035/660; Злокачественные новообразования в России в 2023 году (заболеваемость и смертность). Под ред. А.Д. Каприна. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2024, 276 с. Доступно по: https://oncology-association.ru/wp-content/uploads/2024/08/zis-2023-elektronnaya-versiya.pdf Дата обращения: 19. 11. 2024; Зыкова Т. А., Неродо Г. А., Богомолова О. А., Дурицкий М. Н., Сустретов В. А., Никитина В. П. и др. Распространенность, вирусная нагрузка и типовое разнообразие ВПЧ высокого онкогенного риска среди больных с воспалительными и опухолевыми заболеваниями. Медицинский вестник Юга России. 2018;9(1):42–50. doi:10.21886/2219‑8075‑2018‑9‑1‑42‑50; Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209–249. doi:10.3322/caac.21660; Ульрих Е. А., Урманчеева А. Ф., Артемьева А. С., Вербитская Е. А., Дикарева Е. Л., Комличенко Э. В и др. Редкие злокачественные гинекологические опухоли. СПб.: ООО «Эко‑Вектор»; 2022, 247 с.; Lu KH, Broaddus RR. Endometrial cancer. N Engl J Med. 2020. Nov 19; 383(21):2053–2064. doi:10.1056/NEJMra1514010; Monk BJ, Smith G, Lima J, Long GH, Alam N, Nakamura H, Meulendijks D, et al. Real‑world outcomes in patients with advanced endometrial cancer: A retrospective cohort study of US electronic health records. Gynecol Oncol. 2022 Feb;164(2):325–332. doi:10.1016/j.ygyno.2021.12.008; Simon MS, Hastert TA, Barac A, Banack HR, Caan BJ, Chlebowski RT, et al. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative. Cancer. 2021 Feb 15;127(4):598–608. doi:10.1002/cncr.33295; Zhang Z, Gao P, Bao Z, Zeng L, Yao J, Chai D, et al. Clear cell carcinoma of the endometrium: evaluation of prognostic parameters in 27 cases. Front Oncol. 2021;11:732782. doi:10.3389/fonc.2021.732782; Bogani G, Ray‑Coquard I, Concin N, Ngoi NYL, Morice P, Enomoto T, et al. Clear cell carcinoma of the endometrium. Gynecol Oncol. 2022;164:658–666. doi:10.1016/j.ygyno.2022.01.012; Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022 Apr 9;399(10333):1412–1428. doi:10.1016/S0140‑6736(22)00323‑3; Nigon E, Lefebvre‑Pless C, Martinez A, Scholer C, Lortholary A, Favier L, et al. Clinical, pathological and comprehensive molecular analysis of clear cell uterine cancer: a retrospective national study of the TMRG and GINECO network. Jay Transl Med. 2023;21:408. doi:10.1186/s12967‑023‑04264‑7; Kim SR, Cloutier BT, Leung S, Cochrane D, Britton H, Pina A. Molecular subtypes of clear cell endometrial cancer: possibilities for prognostic and predictive stratification Gynecol. Oncol. 2020;15:3–11. doi:10.1016/j.ygyno.2020.04.043; Spoor E., Cross P. Audit of Endometrial Cancer Pathology for a Regional Gynecological Oncology Multidisciplinary Meeting. Int J Gynecol Pathol. 2019;38(6):514–519. doi:10.1097/PGP.0000000000000547; Zhang G, Nie F, Zhao W, Han P, Wen J, Cheng X, et al. Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population‑based study. World J Surg Oncol. 2023 Nov 21;21(1):357. doi:10.1186/s12957‑023‑03241‑0; Li S, Yi Z, Li M, Zhu Z. An analysis of adjuvant chemoradiotherapy versus chemotherapy on the survival rates for patients with stage IB‑III uterine serous carcinoma. Sci Rep. 2024 Mar 11;14(1):5884. doi:10.1038/s41598‑024‑53172‑3; Франциянц Е. М., Моисеенко Т. И., Шейко Е. А., Бандовкина В. А., Адамян М. Л. Рак эндометрия и стероидные гормоны (обзор литературы). Онкогинекология. 2019;4(32):70–79.; Dong C, Zhao L, Liu X, Dang L, Zhang X. Single‑cell analysis reveals landscape of endometrial cancer response to estrogen and identification of early diagnostic markers. PLoS One. 2024 Mar 22;19(3):e0301128. doi:10.1371/journal.pone.0301128; Suarez AA, Felix AS, Cohn DE. Bokhman Redux: Endometrial cancer "types" in the 21 st century. Gynecol Oncol. 2017 Feb;144(2):243–249. doi:10.1016/j.ygyno.2016.12.010; Wilczyński M, Danielska J, Wilczyński J. An update of the classical Bokhman's dualistic model of endometrial cancer. Prz Menopauzalny. 2016 Jun;15(2):63–68. doi:10.5114/pm.2016.61186; Kuijper EA, Ket JC, Caanen MR, Lambalk CB. Reproductive hormone concentrations in pregnancy and neonates : a systematic review. Reprod Biomed Online. 2013 Jul;27(1):33–63. doi:10.1016/j.rbmo.2013.03.009 Erratum in: Reprod Biomed Online. 2013 Oct;27(4):448–449.; Kolokythas A, Betschart C, Wunder D, Janka H, Stute P. Impact of vaginal estriol on serum hormone levels : a systematic review. Climacteric. 2024 Apr;27(2):137–153. doi:10.1080/13697137.2023.2287624; Meziano S. Endocrinology of human pregnancy and fetal‑placental neuroendocrine development. Editor(s): Jerome F. Strauss, Robert L. Barbieri, Iain and Jaffe's Reproductive Endocrinology (Eighth Edition), Elsevier. 2019: 256–284.e9. doi:10.1016/b978‑0‑323‑47912‑7.00011‑1; Zhou Y, Gu B, Brichant G, Singh JP, Yang H, Chang H, et al. The steroid hormone estriol (E3) regulates epigenetic programming of fetal mouse brain and reproductive tract. BMC Biol. 2022 May 2;20(1):93. doi:10.1186/s12915‑022‑01293‑4; Sánchez‑Rovira P, Hirschberg AL, Gil‑Gil M, Bermejo‑De Las Heras B, Nieto‑Magro C. A Phase II Prospective, Randomized, Double‑Blind, Placebo‑Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor‑Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting. Oncologist. 2020 Dec;25(12):e1846–1854. doi:10.1634/theoncologist.2020‑0417; Nekrasova I, Glebezdina N, Maslennikova I, Danchenko I, Shirshev S. Estriol and commensal microflora strains regulate innate lymphoid cells functional activity in multiple sclerosis. Mult Scler Relat Disord. 2024 Mar;83:105453. doi:10.1016/j.msard.2024.105453; Zhu D, Yang J, Xu J. G‑Protein‑Coupled Estrogen Receptor Enhances the Stemness of Triple‑Negative Breast Cancer Cells and Promotes Malignant Characteristics. Oncologie. 2022;24(3):471–482. doi:10.32604/oncologie.2022.024062; Cui J, Li M, Pang R, Liu Y. Research on Clinical Effectiveness of Aspirin for Treating Breast Cancer and Cell Protein Biomarkers on Aspirin Treatment in Drug‑Resistant Estrogen Receptor‑Positive Breast Cancer Cells. Oncologie. 2022;24(4):743–768. doi:10.32604/oncologie.2022.025419; Hu G, Zhang J, Zhou X, Liu J, Wang Q, Zhang B. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma. Pathology, research and practice. 2020;216(10):153149. doi:10.1016/j.prp.2020.153149; Pinton G, Manzotti B, Balzano C, Moro L. Expression and clinical implications of estrogen receptors in thoracic malignancies : A narrative review. J. Thorac. Dis. 2021;13:1851–1863. doi:10.21037/jtd‑20‑2277; Yu K, Huang ZY, Xu XL, Li J, Fu XW, Deng SL. Estrogen Receptor Function: Impact on the Human Endometrium. Front Endocrinol (Lausanne). 2022 Feb 28;13:827724. doi:10.3389/fendo.2022.827724; Przewoźny S, Rogaliński J, de Mezer M, Markowska A, Markowska J, Żurawski J. Estrogen Receptor (ER) and Progesterone Receptor (PgR) Expression in Endometrial Cancer‑An Immunohistochemical Assessment. Diagnostics (Basel). 2024 Feb 1;14(3):322. doi:10.3390/diagnostics14030322; Eder IE, Kulig Z, Putz T, Nessler‑Menardi K, Bartsch G, Klocker H. Molecular biology of androgen receptors: from molecular understanding to the clinic. Euro Urol. 2001;40:241–251. doi:10.1159/000049782; Viehweger F, Hoop J, Tinger LM, Bernreuther C, Büscheck F, Clauditz TS. Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors. Biomedicines. 2024 Apr 25;12(5):957. doi:10.3390/biomedicines12050957; https://www.rpmj.ru/rpmj/article/view/1035

  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal